메뉴 건너뛰기




Volumn 14, Issue 1, 2003, Pages 49-59

HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor β-D-2′,3′-dideoxy-2′,3′didehydro-5- fluorocytidine (Reverset™)

Author keywords

Multidrug resistance; Nucleoside analogue; Resistance

Indexed keywords

BETA DEXTRO 2',3' DIDEOXY 2',3' DIDEHYDRO 5 FLUOROCYTIDINE; CYTIDINE DERIVATIVE; DIDANOSINE; ELVUCITABINE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

EID: 12444325183     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020301400105     Document Type: Article
Times cited : (38)

References (31)
  • 1
    • 0033169086 scopus 로고    scopus 로고
    • Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy
    • Balzarini J (1999) Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy. Biochemistry & Pharmacology 58:1-27.
    • (1999) Biochemistry & Pharmacology , vol.58 , pp. 1-27
    • Balzarini, J.1
  • 2
    • 0033921632 scopus 로고    scopus 로고
    • In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-β-D-dioxolane-guanosine and suppress resistance to 3′-azido-3′-deoxythymidine
    • Bazmi HZ, Hammond J, Cavalcanti SCH, Chu CK, Schinazi RF & Mellors JW (2000) In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-β-D-dioxolane-guanosine and suppress resistance to 3′-azido-3′-deoxythymidine. Antimicrobial Agents & Chemotherapy 44:1783-1788.
    • (2000) Antimicrobial Agents & Chemotherapy , vol.44 , pp. 1783-1788
    • Bazmi, H.Z.1    Hammond, J.2    Cavalcanti, S.C.H.3    Chu, C.K.4    Schinazi, R.F.5    Mellors, J.W.6
  • 4
    • 0033933688 scopus 로고    scopus 로고
    • A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: The OzCombo 1 study
    • Carr A., Chuah J, Hudson J, French M, Hoy J, Law M, Sayer D, Emery S, & Cooper D (2000) A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo 1 study. AIDS 14:1171-1180.
    • (2000) AIDS , vol.14 , pp. 1171-1180
    • Carr, A.1    Chuah, J.2    Hudson, J.3    French, M.4    Hoy, J.5    Law, M.6    Sayer, D.7    Emery, S.8    Cooper, D.9
  • 5
    • 0001822944 scopus 로고    scopus 로고
    • Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine
    • Coakley EP, Gillis JM & Hammer SM (2000) Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. AIDS 14:F9-F15.
    • (2000) AIDS , vol.14
    • Coakley, E.P.1    Gillis, J.M.2    Hammer, S.M.3
  • 6
    • 0035158709 scopus 로고    scopus 로고
    • Establishment of new transmissible and drug sensitive human immunodeficiency virus type I wilt types due to transmission of nucleoside analogue-resistant virus
    • De Ronde A, van Dooren M, van der Hoek L, Bouwhuis D, de Rooij E, van Gemin B, de Boer R & Goudsmit J (2001) Establishment of new transmissible and drug sensitive human immunodeficiency virus type I wilt types due to transmission of nucleoside analogue-resistant virus. Journal of Virology 75:595-602.
    • (2001) Journal of Virology , vol.75 , pp. 595-602
    • De Ronde, A.1    Van Dooren, M.2    Van der Hoek, L.3    Bouwhuis, D.4    De Rooij, E.5    Van Gemin, B.6    De Boer, R.7    Goudsmit, J.8
  • 8
    • 0028300765 scopus 로고
    • Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells
    • Gao W-Y, Agbaria R, Driscoll JS & Mitsuya H (1994) Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. Journal of Biological Chemistry 269:12633-12638.
    • (1994) Journal of Biological Chemistry , vol.269 , pp. 12633-12638
    • Gao, W.-Y.1    Agbaria, R.2    Driscoll, J.S.3    Mitsuya, H.4
  • 9
    • 0142100752 scopus 로고    scopus 로고
    • The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain terminated DNA synthesis
    • Gotte M, Arion D, Parniak MA & Wainberg MA (2000) The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain terminated DNA synthesis. Journal of Virology 74:3579-3585.
    • (2000) Journal of Virology , vol.74 , pp. 3579-3585
    • Gotte, M.1    Arion, D.2    Parniak, M.A.3    Wainberg, M.A.4
  • 10
    • 12444260103 scopus 로고    scopus 로고
    • Structural features of nucleoside analog reverse transcriptase inhibitors important in selection of resistance mutations in HIV-1 reverse transcriptase
    • Scottsdale, Ariz., USA, June 4-9, 2001
    • Hammond JL, Schinazi RF, Chu CK & Mellors JW (2001) Structural features of nucleoside analog reverse transcriptase inhibitors important in selection of resistance mutations in HIV-1 reverse transcriptase. 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scottsdale, Ariz., USA, June 4-9, 2001.
    • (2001) 5th International Workshop on HIV Drug Resistance & Treatment Strategies
    • Hammond, J.L.1    Schinazi, R.F.2    Chu, C.K.3    Mellors, J.W.4
  • 12
    • 0001812073 scopus 로고    scopus 로고
    • Resistance to antiretroviral drugs - An emerging problem
    • Hirsch MS (1998) Resistance to antiretroviral drugs - an emerging problem. AIDS 12:6-7.
    • (1998) AIDS , vol.12 , pp. 6-7
    • Hirsch, M.S.1
  • 13
    • 0031022510 scopus 로고    scopus 로고
    • Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild types and protease inhibitor resistant mutants of HIV
    • Jadhav P K, Ala P, Woerner FJ, Chang CH, Garber S, Anton EA & Bacheler LT (1997) Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild types and protease inhibitor resistant mutants of HIV. Journal of Medical Chemistry 40:181-190.
    • (1997) Journal of Medical Chemistry , vol.40 , pp. 181-190
    • Jadhav, P.K.1    Ala, P.2    Woerner, F.J.3    Chang, C.H.4    Garber, S.5    Anton, E.A.6    Bacheler, L.T.7
  • 14
    • 0035371314 scopus 로고    scopus 로고
    • Vertical transmission of multidrug resistant human immunodeficiency virus type 1 (HIV-2) and continued evolution of drug resistance in an HIV-1 infected infant
    • Johnson VA, Petropoulos CJ, Woods CR, Hazelwood JD, Parkin NT, Hamilton CD & Fiscus SA (2001) Vertical transmission of multidrug resistant human immunodeficiency virus type 1 (HIV-2) and continued evolution of drug resistance in an HIV-1 infected infant. Journal of Infectious Diseases 183:1688-1693.
    • (2001) Journal of Infectious Diseases , vol.183 , pp. 1688-1693
    • Johnson, V.A.1    Petropoulos, C.J.2    Woods, C.R.3    Hazelwood, J.D.4    Parkin, N.T.5    Hamilton, C.D.6    Fiscus, S.A.7
  • 15
    • 0035173806 scopus 로고    scopus 로고
    • Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents
    • Lee K & Chu CK (2001) Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents. Antimicrobial Agents & Chemotherapy 45:138-144.
    • (2001) Antimicrobial Agents & Chemotherapy , vol.45 , pp. 138-144
    • Lee, K.1    Chu, C.K.2
  • 16
    • 0034456474 scopus 로고    scopus 로고
    • Resistance against reverse transcriptase inhibitors
    • O'Brien WA (2000) Resistance against reverse transcriptase inhibitors. Clinical Infectious Diseases Suppl. 2:185-192
    • (2000) Clinical Infectious Diseases , Issue.SUPPL. 2 , pp. 185-192
    • O'Brien, W.A.1
  • 17
    • 0032192444 scopus 로고    scopus 로고
    • Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies
    • Pastor-Anglada M, Felipe A & Casado FJ (1998) Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends in Pharmaceutical Sciences 19:424-430.
    • (1998) Trends in Pharmaceutical Sciences , vol.19 , pp. 424-430
    • Pastor-Anglada, M.1    Felipe, A.2    Casado, F.J.3
  • 20
    • 0034083833 scopus 로고    scopus 로고
    • Mutations in retroviral genes associated with drug resistance: 2000-2001 Update
    • Schinazi RF, Larder BA & Mellors JW (2001) Mutations in retroviral genes associated with drug resistance: 2000-2001 update. International Antiviral News 8:65-81.
    • (2001) International Antiviral News , vol.8 , pp. 65-81
    • Schinazi, R.F.1    Larder, B.A.2    Mellors, J.W.3
  • 22
    • 0036001225 scopus 로고    scopus 로고
    • Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry
    • Shi G, Wu JT, Li Y, Geleziunas R, Gallagher K, Emm T, Olah T & Unger S (2002) Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 16:1092-1099.
    • (2002) Rapid Communications in Mass Spectrometry , vol.16 , pp. 1092-1099
    • Shi, G.1    Wu, J.T.2    Li, Y.3    Geleziunas, R.4    Gallagher, K.5    Emm, T.6    Olah, T.7    Unger, S.8
  • 23
    • 0035876456 scopus 로고    scopus 로고
    • Phenotypic hypersusceptibiity to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: Impact on virological response to efavirenz-based therapy
    • Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropolos C & Whitcomb J (2001) Phenotypic hypersusceptibiity to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy. AIDS 15:1125-1132.
    • (2001) AIDS , vol.15 , pp. 1125-1132
    • Shulman, N.1    Zolopa, A.R.2    Passaro, D.3    Shafer, R.W.4    Huang, W.5    Katzenstein, D.6    Israelski, D.M.7    Hellmann, N.8    Petropolos, C.9    Whitcomb, J.10
  • 25
    • 0031798147 scopus 로고    scopus 로고
    • Pharmacological considerations in antiretroviral therapy
    • Sommadossi JP (1998) Pharmacological considerations in antiretroviral therapy. Antiviral Therapy 3:9-12.
    • (1998) Antiviral Therapy , vol.3 , pp. 9-12
    • Sommadossi, J.P.1
  • 27
    • 0035174783 scopus 로고    scopus 로고
    • Phosphorylation of nucleoside analog antiretrovirals: A review for clinicians
    • Stein DS & Moore KHP (2001) Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians. Pharmacotherapy 21:11-34.
    • (2001) Pharmacotherapy , vol.21 , pp. 11-34
    • Stein, D.S.1    Moore, K.H.P.2
  • 29
    • 0029792465 scopus 로고    scopus 로고
    • Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266
    • Winslow DL, Garber S, Reid C, Scarnati H, Baker D, Rayner MM & Anton ED (1996) Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS 10:1205-1209.
    • (1996) AIDS , vol.10 , pp. 1205-1209
    • Winslow, D.L.1    Garber, S.2    Reid, C.3    Scarnati, H.4    Baker, D.5    Rayner, M.M.6    Anton, E.D.7
  • 30
    • 0028988566 scopus 로고
    • Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors
    • Winslow DL, Stack S, King R, Scarnati H, Bincsik A & Otto MJ (1995) Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. AIDS Research & Human Retroviruses 11:107-113.
    • (1995) AIDS Research & Human Retroviruses , vol.11 , pp. 107-113
    • Winslow, D.L.1    Stack, S.2    King, R.3    Scarnati, H.4    Bincsik, A.5    Otto, M.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.